CA Stock MarketDetailed Quotes
BIOV BioVaxys Technology Corp
- 0.060
- -0.005-7.69%
15min DelayTrading Jul 17 09:46 ET
13.21MMarket Cap-1500P/E (TTM)
0.060High0.060Low35.70KVolume0.060Open0.065Pre Close2.14KTurnover0.10052wk High0.02%Turnover Ratio220.24MShares0.01052wk Low-0.04EPS TTM11.79MFloat Cap0.780Historical HighLossP/E (Static)196.46MShs Float0.010Historical Low-0.06EPS LYR0.00%Amplitude--Dividend TTM-12.00P/B1Lot Size--Div YieldTTM
BioVaxys Technology Corp Key Stats
Quarterly+Annual
YOY
| (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | (Q3)Jul 31, 2023 | (Q2)Apr 30, 2023 | (Q1)Jan 31, 2023 | (FY)Oct 31, 2022 | (Q4)Oct 31, 2022 | (Q3)Jul 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -31.12%539.19K | -59.49%370.7K | 58.10%6.45M | 353.82%4.19M | -38.18%562.23K | -24.73%782.8K | -24.27%915.07K | -36.64%4.08M | -63.26%923.96K | 1.80%909.44K |
| Selling and administrative expenses | -5.17%486.14K | -40.80%341.26K | -20.20%2.26M | 10.41%863.95K | -44.14%309.57K | -17.32%512.65K | -34.39%576.44K | -46.02%2.84M | -55.41%782.5K | -30.11%554.18K |
| -Selling and marketing expense | 231.36%45.32K | --8.22K | --0 | -111.12%-13.68K | --0 | -73.33%13.68K | --0 | -89.87%174.3K | -80.91%123.01K | --0 |
| -General and administrative expense | -11.65%440.82K | -42.22%333.04K | -14.97%2.26M | 33.08%877.63K | -44.14%309.57K | -12.26%498.97K | -34.39%576.44K | -24.68%2.66M | -40.60%659.49K | -2.43%554.18K |
| Research and development costs | --0 | --0 | -86.11%133.73K | -133.62%-31.17K | -88.76%31.79K | -96.42%13.33K | -44.33%119.78K | 32.59%962.71K | -85.23%92.7K | 24,994.10%282.8K |
| Other operating expenses | -79.34%53.05K | -86.55%29.44K | 1,329.14%4.06M | 6,792.78%3.36M | 204.80%220.87K | 435.81%256.82K | 90.77%218.85K | -38.74%283.87K | -63.27%48.75K | -28.72%72.46K |
| Operating profit | 31.12%-539.19K | 59.49%-370.7K | -58.10%-6.45M | -353.82%-4.19M | 38.18%-562.23K | 24.73%-782.8K | 24.27%-915.07K | 36.64%-4.08M | 63.26%-923.96K | -1.80%-909.44K |
| Net non-operating interest income (expenses) | 0 | 0 | 57.56%24.85K | 284.10%15.26K | -12.39%3.34K | -15.96%3.2K | -27.10%3.05K | 106.00%15.77K | -35.33%3.97K | 1,186.82%3.81K |
| Non-operating interest income | --0 | --0 | 57.56%24.85K | 284.10%15.26K | -12.39%3.34K | -15.96%3.2K | -27.10%3.05K | 106.00%15.77K | -35.33%3.97K | 1,186.82%3.81K |
| Other net income (expenses) | 99.55%-3.2K | 2,118.65%888.75K | 83.57%-1.26M | 106.70%511.18K | -15,438.96%-1.02M | -3,254.96%-709.58K | -525.92%-44.03K | -32,416.01%-7.66M | -70,334.95%-7.63M | 45.41%-6.54K |
| Gain on sale of security | -104.79%-3.2K | 121.13%8.37K | -66.91%-27.53K | -367.23%-48.73K | 9.95%-5.89K | 415.34%66.69K | -462.95%-39.6K | 30.01%-16.49K | 268.41%18.24K | 45.41%-6.54K |
| Special income (charges) | --0 | --0 | 81.65%-1.4M | 107.32%559.91K | ---1.01M | ---947.46K | ---4.43K | ---7.64M | ---7.64M | --0 |
| -Less:Impairment of capital assets | --0 | ---- | -80.46%1.45M | -106.94%-513.03K | --1.01M | --947.46K | ---- | --7.4M | --7.4M | --0 |
| -Less:Other special charges | ---- | ---- | -117.11%-42.45K | ---46.88K | ---- | ---- | --4.43K | --248.11K | ---- | ---- |
| Other non-operating income (expenses) | ---- | --880.39K | --171.2K | --0 | ---- | --171.2K | ---- | ---- | ---- | ---- |
| Income before tax | 63.58%-542.39K | 154.19%518.05K | 34.45%-7.69M | 57.10%-3.67M | -72.71%-1.58M | -40.84%-1.49M | 21.07%-956.05K | -81.60%-11.73M | -239.19%-8.55M | -0.78%-912.17K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 63.58%-542.39K | 154.19%518.05K | 34.45%-7.69M | 57.10%-3.67M | -72.71%-1.58M | -40.84%-1.49M | 21.07%-956.05K | -81.60%-11.73M | -239.19%-8.55M | -0.78%-912.17K |
| Net income continuous operations | 63.58%-542.39K | 154.19%518.05K | 34.45%-7.69M | 57.10%-3.67M | -72.71%-1.58M | -40.84%-1.49M | 21.07%-956.05K | -81.60%-11.73M | -239.19%-8.55M | -0.78%-912.17K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 63.58%-542.39K | 154.19%518.05K | 34.45%-7.69M | 57.10%-3.67M | -72.71%-1.58M | -40.84%-1.49M | 21.07%-956.05K | -81.60%-11.73M | -239.19%-8.55M | -0.78%-912.17K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 63.58%-542.39K | 154.19%518.05K | 34.45%-7.69M | 57.10%-3.67M | -72.71%-1.58M | -40.84%-1.49M | 21.07%-956.05K | -81.60%-11.73M | -239.19%-8.55M | -0.78%-912.17K |
| Diluted earnings per share | 73.95%-0.0026 | 135.66%0.0036 | 50.00%-0.06 | 66.67%-0.03 | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 | -50.00%-0.12 | -200.00%-0.09 | 0.00%-0.01 |
| Basic earnings per share | 73.95%-0.0026 | 135.66%0.0036 | 50.00%-0.06 | 66.67%-0.03 | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 | -50.00%-0.12 | -200.00%-0.09 | 0.00%-0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg